Sandhoff disease in Argentina : high frequency of a splice site mutation in the HEXB gene and correlation between enzyme and DNA-based tests for heterozygote detection

• Published in: Human genetics 1994-09, Vol.94 (3), p.279-282
• Main Authors: KLEIMAN, F. E, DODELSON DE KREMER, R, OLLER DE RAMIREZ, A, GRAVEL, R. A, ARGARANA, C. E
• Format: Article
• Language: English
• Subjects: Argentina - epidemiology; beta -N-acetylhexosaminidase; beta-N-Acetylhexosaminidases - blood; beta-N-Acetylhexosaminidases - genetics; Biological and medical sciences; Clinical Enzyme Tests; DNA Mutational Analysis; Errors of metabolism; Gene Frequency; Genetic Carrier Screening; HEXB gene; Hexosaminidase B; Humans; Incidence; Leukocytes - enzymology; Lipids (lysosomal enzyme disorders, storage diseases); man; Medical sciences; Metabolic diseases; Mutation; Polymerase Chain Reaction; RNA Splicing - genetics; Sandhoff Disease - diagnosis; Sandhoff Disease - epidemiology; Sandhoff Disease - genetics; Sandhoff's disease; splice sites; Tropical medicine
• ISSN: 0340-6717; 1432-1203
• DOI: 10.1007/BF00208283

The level of beta-hexosaminidase activity in plasma and leukocytes and the frequency of three known HEXB mutations were studied in an Argentinean deme with high incidence of infantile Sandhoff disease. Two mutations were previously identified in one of two Sandhoff patients from the region, a splice mutation, IVS-2 + 1 G-->A, and a 4-bp deletion, delta CTTT782-785. These mutations, and a 16-kb deletion from the 5' end of the HEXB gene common in non-Argentineans, were screened in 9 Sandhoff patients (all unrelated), 24 obligate heterozygotes, 33 additional individuals belonging to families with affected members, and 64 randomly ascertained individuals from the high risk region. Of 31 independent alleles examined, including those of the two patients previously reported, 30 had the IVS-2 splice mutation and only the originally reported patient had the delta CTTT deletion. The 16-kb deletion was not observed. Further, among the 57 unaffected members of families with a previous history of Sandhoff disease, and absolute correlation was found between carrier diagnosis by enzyme assay of leukocytes and the DNA-based tests for mutation. One of the 64 controls was classified as a carrier by enzyme assay but did not have one of the three mutations screened. We conclude that a single mutation predominates in this Argentinean population and that the DNA-based test can be an effective supplement or alternative to enzyme-based testing.